HIV T-Cell Vaccines
- 21 July 2018
- book chapter
- Published by Springer Nature
- Vol. 1075, 31-51
Abstract
Some of the strongest immune correlates of controlled HIV infection include markers related to antiviral T-cell responses, especially responses mediated by CD8+ cytotoxic T lymphocytes (CTL). These observations and lessons learned from other viral infections have motivated the development of T-cell vaccine candidates to HIV in the preventive and especially in the therapeutic setting. While none of the T-cell vaccine concepts tested to date have shown sufficient efficacy, the last few years have seen some advances indicating that strategies activating the cellular adaptive immune response to HIV may present a critical component of an effective therapeutic and possibly preventive HIV vaccine. Some of the important components that a successful T-cell vaccine may need to contain and additional considerations for the design and delivery of such vaccines are discussed in this chapter.Keywords
This publication has 91 references indexed in Scilit:
- Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective EfficacyThe Journal of Immunology, 2017
- Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccinesPLOS ONE, 2017
- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 PreventionAnnals of Internal Medicine, 2016
- Selection and Accumulation of an HIV-1 Escape Mutant by Three Types of HIV-1-Specific Cytotoxic T Lymphocytes Recognizing Wild-Type and/or Escape Mutant EpitopesJournal of Virology, 2012
- High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV ControlJournal of Virology, 2011
- Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele AssociationsScience, 2007
- Hitting HIV where it hurts: an alternative approach to HIV vaccine designTrends in Immunology, 2006
- Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Journal of Translational Medicine, 2005
- Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus SequencesJournal of Virology, 2003
- Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.Proceedings of the National Academy of Sciences, 1996